main-logo

ICD-10 Code D05.02 | Lobular carcinoma in situ of left breast Symptoms, Diagnosis, Billing

Lobular carcinoma in situ (LCIS) of the left breast is a non-invasive breast cancer characterized by abnormal cell growth in the lobules of the breast. While LCIS is not considered a true breast cancer, it is a marker for increased risk of developing invasive breast cancer in the future. Accurate coding with ICD-10 Code D05.02 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate surveillance and management.

What is ICD-10 Code D05.02 for Lobular carcinoma in situ of left breast?

ICD-10 Code D05.02 specifically denotes lobular carcinoma in situ of the left breast. This condition involves the proliferation of atypical cells within the lobules, which can lead to an increased risk of subsequent invasive breast cancer. This code should be utilized in clinical documentation and billing when diagnosing patients with LCIS, ensuring accurate representation of the patient's condition for treatment planning and insurance reimbursement.

ICD-10 Code D05.02 – Clinical Definition and Explanation of Lobular carcinoma in situ of left breast

Lobular carcinoma in situ of the left breast is a non-invasive neoplasm that arises from the lobular epithelium. It is characterized by small, non-cohesive clusters of atypical cells that fill the lobules. Although it does not typically present with symptoms, it requires careful monitoring due to its association with an elevated risk of developing invasive breast cancer.

Key Clinical Features:

  • Often asymptomatic and discovered incidentally during biopsies
  • Increased risk of developing invasive breast cancer in either breast
  • Typically diagnosed in women aged 40-50 years
  • May be bilateral in some cases
  • Requires regular follow-up and surveillance for early detection of invasive disease.

ICD-10 Code D05.02 for Lobular carcinoma in situ of left breast – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code D05.02 is utilized to document the diagnosis of lobular carcinoma in situ of the left breast. This code plays a crucial role in capturing the patient's clinical history, assessment findings, and treatment plans, facilitating continuity of care and appropriate billing in both acute and chronic care settings.

What Does ICD-10 Code D05.02 for Lobular carcinoma in situ of left breast Mean in SOAP Notes?

ICD-10 Code D05.02 connects subjective patient reports and objective clinical findings to a formal diagnosis of lobular carcinoma in situ of the left breast. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.

Treatment Options for ICD-10 Code D05.02 – Lobular carcinoma in situ of left breast

Management of lobular carcinoma in situ of the left breast typically involves careful monitoring rather than immediate invasive treatment. Regular follow-up is essential to assess for any progression to invasive disease.

Antibiotic Therapy:

  • Not applicable as LCIS is not an infectious condition.

Supportive Care:

  • Regular clinical breast examinations and imaging studies (e.g., mammograms) every 6-12 months
  • Patient education regarding breast self-exams and awareness of changes
  • Discussion of risk-reducing strategies, including lifestyle modifications.

Infection Control:

  • Not applicable as LCIS is not an infectious condition.

How to Document Symptoms of Lobular carcinoma in situ of left breast (ICD-10 D05.02) in SOAP Notes

Subjective:

  • Patient reports no symptoms; condition discovered incidentally
  • Family history of breast cancer noted
  • Patient expresses concern about future breast cancer risk
  • Patient inquires about surveillance recommendations.

Objective:

  • Clinical breast examination reveals no palpable masses
  • Mammogram shows no suspicious findings
  • Biopsy confirms diagnosis of lobular carcinoma in situ of left breast
  • No lymphadenopathy detected on examination.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Lobular carcinoma in situ of left breast (ICD-10 Code D05.02)

Assessment:

  • Diagnosis: Lobular carcinoma in situ of left breast, non-invasive, low risk for immediate progression.
  • ICD-10 Code: D05.02
  • Contributing factors: Family history of breast cancer, age.

Plan:

  • Schedule follow-up mammogram in 6 months.
  • Educate patient on breast self-examination techniques.
  • Discuss lifestyle modifications to reduce breast cancer risk.
  • Plan for annual clinical breast exams.

Treatment & Plan Section for ICD-10 Code D05.02 – Lobular carcinoma in situ of left breast

  • Regular surveillance with clinical exams and imaging studies.
  • Patient education on risk factors and self-monitoring.
  • Consideration of prophylactic mastectomy in high-risk patients.
  • Referral to genetic counseling if indicated.

Using ICD-10 Code D05.02 for Lobular carcinoma in situ of left breast in Billing & SOAP Note Compliance

  • Ensure accurate documentation of diagnosis in the Subjective (S) and Objective (O) sections.
  • Utilize D05.02 for billing to reflect the patient's non-invasive condition.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Document any relevant family history or risk factors to enhance coding accuracy.

ICD-10 Code D05.02 in Medical Billing and Insurance for Lobular carcinoma in situ of left breast

ICD-10 Code D05.02 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate reimbursement for services related to lobular carcinoma in situ of the left breast.

Billing Notes:

  • Document the diagnosis clearly in the medical record to support claims.
  • Use D05.02 in conjunction with relevant CPT codes for procedures and consultations.
  • Ensure that all clinical findings and treatment plans are well-documented.

Common CPT Pairings:

CPT CodeDescription
99213Established patient office visit, Level 3.
77067Mammography, bilateral, including CAD.
88305Level IV surgical pathology, gross and microscopic examination.

Frequently Asked Questions

Common Questions About Using ICD-10 Code D05.02 for Lobular carcinoma in situ of left breast

What is lobular carcinoma in situ?

Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells grow in the lobules of the breast. While it is not considered breast cancer, it indicates an increased risk for developing invasive breast cancer in the future.

How is lobular carcinoma in situ diagnosed?

LCIS is typically diagnosed through a breast biopsy, often performed after an abnormal mammogram or clinical examination. It may be discovered incidentally during the evaluation of other breast conditions.

What are the treatment options for lobular carcinoma in situ?

Management of LCIS usually involves regular monitoring and surveillance rather than immediate treatment. Patients may be advised on lifestyle changes and risk-reducing strategies.

Is lobular carcinoma in situ hereditary?

While LCIS itself is not hereditary, it is associated with genetic factors that may increase breast cancer risk. Family history should be evaluated to determine the need for genetic counseling.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved